Mouse mammary tumor virus (MMTV)-encoded superantigens (SAGs) influence the murine T cell repertoire and stimulate a strong mixed lymphocyte response in vitro. These SAGs are encoded by the open reading frame of the 3' long terminal repeat of MMTV, termed MMTV SAGs. The T cell response to MMTV SAGs is V/3 restricted and requires expression of the class II molecules of the major histocompatibility complex (MHC) on the presenting cells. While human T cells respond to bacterial SAGs, it is not known if human T cells or human MHC class II molecules can interact with MMTV SAGs. A fibroblastic cell line expressing the human MHC class II molecule HLA-DR1 and the Mtv-7 sag gene encoding Mls-1 was used to stimulate human T cells. We show here that human T cells efficiently proliferate in response to Mls-1 presented by HLA-DR1. This T cell response was inhibited by mAbs directed against CD4 or MHC class II molecules but not by mAbs specific for CD8 or MHC class I molecules. Moreover, the response to Mls-1 was limited to human T cells expressing a restricted set of T cell receptor V/3 chains. Human T cells expressing V~12, 13, 14, 15, and 23 were selectively amplified after Mtv-7 sag stimulation. Interestingly, these human V/~s share the highest degree of homology with the mouse V~s interacting with Mls-1. These results show a strong evolutionary conservation of the structures required for the presentation and the response to retrovirally encoded endogenous SAGs, raising the possibility that similar elements operate in humans to shape the T cell repertoire.
S
uperantigens (SAGs) 1 are a new class of Ags that stimulate a large number of human and mouse T cells expressing specific variable regions of the TCR/3 chain (1-3). The response of T cells to SAG requires the expression of MHC class II molecules on the cell surface of the APCs (1, 4, 5) . Unlike nominal antigens, SAGs are not processed into peptides by APCs. Two sets of molecules have been shown to exhibit the properties of SAGs. Bacterial toxins expressed by Staphylococcus and Streptococcus bacteria stimulate large number of T cells after their interaction with MHC class II molecules. More recently, protein products encoded within the 3' LTR of mouse mammary tumor virus (MMTV) were shown to be directly associated with Mls SAG reactivity (6) (7) (8) (9) (10) (11) (12) .
In the mouse, molecules of the Mls loci are directly involved in shaping the TCR repertoire (13) (14) (15) . Genetic analysis of recombinant mouse strains established a direct corre-
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RT, reverse transcriptase; SAG, superantigen. lation between endogenous MMTV integrants and the expression of Mls Ags (6) (7) (8) . Moreover, exogenous MMTVs were also shown to be directly responsible for the deletion of specific sets of V3s (9) (10) (11) (12) . Transfection of class II + cells with the sag gene of endogenous or infectious MMTVs is sufficient to stimulate T cells expressing particular V/3s (16) (17) (18) . Mtv-7 sag encodes Mls-1, which stimulates in vitro and deletes in vivo T cells expressing the murine V/~6, 7, 8.1, and 9 chains (14, 15, 19) .
Retroviruses of the MMTV family are responsible for mammary tumors (20) . Recent reports have shown that the SAG encoded by infectious MMTV is directly responsible for mammary tumors (21) . Other reports have suggested a role for SAGs in autoimmune diseases and immunodeficiencies both in mouse and in human (22) (23) (24) (25) (26) . While human T cells readily respond to bacterial SAGs, little is known about their capacity to respond to vitally encoded SAGs. One recent report has suggested that the rabies virus nucleoprotein can stimulate human T cells in a Vfl-specific fashion (27) . It becomes important to determine whether human MHC class II mole-cules can present or human TCR ~ chains can respond to retrovirally encoded SAGs.
To analyze this question, we have used murine fibroblasts expressing the human MHC class II molecule HLA-DR1 and the Mtv-7 sag Mls-1 to stimulate human T cells in vitro.
Specific stimulation of human T cells bearing a restricted number ofVB gene segments was shown. Moreover, the TCR VBs expressed on the human T cells responding to Mls-1 exhibited a strong degree of homology to the mouse VBs, which are stimulated by Mls-1.
Materials and Methods
Antibodies. mAbs against the human TCR B chain used in this study were $511 (V/$12. b243 is an anti-HLA-DR mAb, BL4 and OKT4 are anti-human CD4 mAbs, W6-32 in an anti-human MHC class I mAb, OKT8 is an anti-human CD8, and Leu-4 is a human CD3-specific mAb. Hybridomas were obtained from American Type Culture Collection (Kockville, MD).
Human T Cell Purification. T cells were purified from peripheral blood of DR1 + individuals using rosetting with SRBC (Quelab, Montr6al, Qu6bec, Canada). Briefly, peripheral blood was diluted in PBS and underlayered with Ficoll-Hypaque (Pharmacia, LKB Biotechnology AB, Uppsala, Sweden). After centrifugation, the interface was collected and diluted with an equal volume of PBS. Cells were washed and resuspended at 5 x 106 cells/ml in PBS. They were then incubated at 1:1 (vol/vol) ratio with FCS (Gibco Laboratories, Grand Island, NY) preabsorbed with SRBC and 2-aminoethylisothiouronium bromide (Sigma Chemical Co., St. Louis, MO) -treated SRBC (1:20) for 10 min at 37~ Cells were then spun down and incubated for an additional I h on ice.
The supernatant was aspirated and the pellet was resuspended in 4 ml of RPMI (Gibco Laboratories) supplemented with 10% FCS (Gibco Laboratories). Cells were separated on Ficoll. SRBC within the T cell pellet were lysed with 5 ml of buffer containing 0.15 M NH4Ct, 9.4 M Na2CO3, 0.1 mM EDTA for 2-5 min at room temperature. Cell suspensions were then diluted and washed. The Ficoll interface was kept to be used as a source of autologous feeder cells. The T cell and non-T cell fractions were stained with anti-CD3 (Leu-4-FITC) and anti-HLA-DR (L-243-bio) mAbs to determine the degree of purity. T cell purity was always >98%, while the non-T cell fraction contained <20% of T cells as confirmed by FACS | analysis (Becton Dickinson & Co., Mountain View, CA). DAP cells transfected with class II molecules are poor stimulator ceils for both aUogeneic and xenogeneic responses (35) . For this purpose, human autologous irradiated non-T cells were added to the coculture, which increased human T cell proliferation by at least twofold (see Fig. 2 B) . The kinetics of the human T cell response to Mls-1 are comparable to what is observed when the same human T cells are stimulated with bacterial SAGs (data not shown). After 48 h of stimulation the T cell response was very low (fivefold), however, a considerable increase (30-fold) is observed by 72 h (Fig. 2 C) . Similar kinetics were observed when two different DR1 + Mls-1 + DAP transfectants were used (Fig. 2 C) .
Presentation of Mtv-7 SAG to Human T Cells Is Inhibited by Anti-CD4 and Anti-HLA-DR but Not by Anti-CD8 and Anti-MHC Class I mAbs. In the murine system, the Mls response is blocked by antibodies directed to MHC class II molecules (36, 37) . To further confirm the similarity of the human T cell response to Mls-1, mAb inhibition experiments were performed. Anti-HLA-DR mAb (L-243) completely inhibited T cell proliferation. This inhibition occurred in a dosedependent fashion, as shown in Fig. 3 , confirming the requirement for MHC class II molecules for an Mtv-7 SAG-specific response. Murine T cells responding to Mls-1 are mostly CD4 + , and CD4-specific mAbs significantly inhibit this response (5) . The human T cell response to DR1 + Mls-1 § cells was inhibited in a dose-dependent manner when anti-CD4 (BL-4) mAb was added to the culture (see Fig. 3 ). However, T cell proliferation was still observed (fourfold over background) at the highest concentration of CD4-specific mAb (2/xg/ml), suggesting that CD4-T cells were also responding to Mls-1. Recent reports have demonstrated that murine CD8 § T cells can also proliferate in response to Mls-1 (38, 39) . Interestingly, anti-CD8 (OKTS) mAb does not affect the T cell response (Fig. 3) , as was previously shown to be the case for murine CD8 + T cells responding to Mls-1 (H. R. McDonald, personal communication). As predicted, anti-MHC class I (W6-32) mAb had no effect on Mls-1 stimulation of human T cells (Fig. 3) . These results further confirm the parallel between human and murine T cell responses to retroviral SAGs. . ~~rVi' , , , , , v,,;., v~,, v. v This selective expansion of human T cells expressing TCR V/312 was reproducible in four separate experiments using two different clones of DR1 + Mls-1 + DAP transfectants (see Fig. 5 ). The increase in V/312-expressing T cells ranged between 3-and 10-fold in these experiments. There was no detectable increase in any of the other V/3s analyzed in these four experiments, strongly confirming the specificity of the V1312 response. Fig. 6 illustrates the number of VB12 + CD4 + and VI312+CD4 -cells responding to the two independently derived DR1 + Mls-1 + DAP transfectants. Both CD4 + and CD4-V/312 + cells proliferated to the DR1 + Mls-1 + clones (Fig. 6) , confirming previous results in the mouse. In three separate experiments the increase in CD4 § T cells was always higher than the one observed in CD4-T cells. This increase in CD4-T cells was never greater than sixfold, while as previously mentioned, CD4 +Vf112 + cells were increased by up to 10-fold.
Mls-1 Presentation by DR1 + DAP Fibroblasts to Human T Cells Increases the Number of TCR
This relative increase in Vt312 + cells was also accompanied by a highly significant increase in the absolute number of T cells. Hence, while T cells cocultured together with DR1 + DAP cells and IL-2 proliferated marginally (threefold increase in cell number), there was a reproducible and strong proliferation to both DR1 + Mls-1 + transfectants (10-33-fold increase in cell number). This increase in cell number was almost parallel to the one observed in T cells stimulated with PHA (10-35 fold). Amplification of V~12, 13, 14, 15, and 23 was consistently seen in three different experiments using human T cells purified from three different DR1 + donors (see Fig. 8 , B, D, and F) when compared with PHA (Fig. 8, A, C, and E) . A 3-10-fold increase in the relative expression of the different VBs was noted in three different individuals tested. Moreover, the two DR1 § Mls-1 § DAP clones reproducibly yielded a selective amplification of V312, 13, 14, 15, and 23 (data not shown).
Selected V~s Are Amplified after Mls-I Stimulation as Determined by PCR

Discussion
In this report, we demonstrate specific stimulation of human T cells to the Mtv-7 sag presented by DR1 + DAP fibroblasts. This T cell stimulation was due to Mls-1 recognition since no T cell proliferation was seen in response to untransfected DR1 + fibroblasts. T cell responses were enhanced by the presence of autologous feeder cells. These cells may provide additional cytokines that help T cell responses. The response of human T cells bears all the characteristics of an Mls-1 stimulation (1); it is inhibited by anti-CD4 and anti--class II mAbs but not by anti-CD8 and anti-class I mAbs. Both CD4 + and CD4-T cells respond to DR1 + Mls-1 + DAP cells; however, unlike antigen-specific responses, proliferation of both T cell subsets is inhibited by DR-specific mAhs, while mAbs to CD8 and to MHC class I do not have an effect. Similar observations have already been described in human and murine T cell responses to bacterial SAGs (1, 40) . The strong primary proliferative response of the human T cells to DR1 + Mls-1 + cells further confirms the parallel with a SAG response.
The hallmark of the response to a SAG is the TCK V3 restriction of the responding T cells. Indeed, the human T cell response to Mtv-7 SAG presented by the human MHC class II molecules, HLA-DK1, is restricted to T cells expressing a limited set of V~s, further confirming the parallel between human and murine T cell responses to this retrovirally encoded SAG. Cytofluorometric analysis, using a restricted set of TCR V~-specific mAbs, has enabled us to demonstrate that CD4 + VB12 + and CD4-V~12 + cells respond to DR1 + Mls-1 + cells. Quantitative PCK analysis of the TCK As previously mentioned, the expansion ranged from 3-to 10-fold and was reproducible in three different individuals irrespective of their MHC haplotype. Interestingly, V312'and V~17 were amplified by PCR only in two of the three individuals tested. Since the V317 family contains only one member, it is possible that polymorphisms in V317 genes analogous to the polymorphisms previously described for the murine V38 and V317 genes (41, 42) confer to some individuals the capacity to respond to Mls-1. The human TCR V3 gene products that recognize Mls-1 share the highest homology with the mouse V~ chains known to be selectively expanded in Mls-1 stimulation (V36, 7, 8.1, and 9). The human V/312 and 13 genes share ,o70% homology in nucleotide sequences with the mouse V38.1 gene, while the human V315 gene is 70% homologous to the mouse V37 gene (43) . Only the human V~23 gene product does not possess strong homology (44-56%) with Mls-l-reactive murine V3s (44) . The homology of the human V~s responding to Mls-1 with other murine V3s that do not respond to Mls-1 varies between 40 and 55% (43) .
The CDR4 of the TCR VB chain encompasses critical residues for the Mls-1 response (42, 45) . Residues 68-76 of the CDR4 loop are predicted to lie on a B-pleated sheet away from the CDR.1-3, which are involved in conventional an-tigen recognition. Critical residues for Mls-1 recognition include amino acids 73 and 74, as shown from V3 polymoro phisms in wild mice and by site-directed mutagenesis studies (41, 42, 45) . Moreover, residue N74 in an Mls-l-nonreactive V3 chain carries a potential glycosylation site. Interestingly, none of the Mls-l-reactive human V3s have potential glycosylation sites in the CDR4. A consensus was derived that dearly shows that two residues, $68 and R69, are conserved in 13 of 14 Mls-l-reactive V~s. A third highly conserved amino acid (F75) is present in almost all other VB sequences. In contrast, only 7 of 38 Mls-l-nonreactive V3s bear these residues. The human V~23, which in our experiments responds very efficiently to DR1 Mtv-7 sag fibroblasts, does not carry these two residues in its CDR.4 sequence. Since only one V~/23 sequence is published so far, it is likely that polymorphisms in this V3 gene could modify the reported VB23 sequence and conferring reactivity of V323 to Mls-1.
The results presented here clearly indicate that human T cells carry all the structural features required for an efficient response to routine retrovirally endogenous encoded SAGs. Moreover, this response involves similar mechanisms to those required for the response of murine T cells to Mls-1. The ability of human T cells to respond to the Mtv-7 SAG and the efficient presentation of this SAG by human MHC class II molecules suggest the possibility that the human genome may contain such SAGs. Several reports have suggested polymorphisms within the human VB locus at the genomic level using Southern blots and VB-specific probes (30, 46, 47) . Some of these polymorphisms have been associated with disease (48) . Using human T cell stimulation with Mls-1, it will be interesting to verify if the presence of polymorphisms or lack thereof in the coding sequence of V~/s is correlated with the response to viral SAGs. Such a demonstration would provide functional evidence for the role of polymorphisms within the TCR VB genes in the deletion of self-reactive V~s or in the association of specific sets of TCR V/3s with autoimmune diseases. Indeed, V~14 has been associated in one study with rheumatoid arthritis (22) , while other groups have failed to observe such a correlation (49) (50) (51) . It is possible that polymorphisms in the VB14 gene could confer to certain individuals the capacity to respond to SAGs encoded by pathogens involved in rheumatoid arthritis. Our experiments provide a model that could be used to identify such functional polymorphisms in TCR VB chains.
